Chi Dae Kim

2.4k total citations
74 papers, 2.0k citations indexed

About

Chi Dae Kim is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Chi Dae Kim has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 19 papers in Physiology and 15 papers in Immunology. Recurrent topics in Chi Dae Kim's work include Nitric Oxide and Endothelin Effects (15 papers), Angiogenesis and VEGF in Cancer (8 papers) and Cell Adhesion Molecules Research (6 papers). Chi Dae Kim is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Angiogenesis and VEGF in Cancer (8 papers) and Cell Adhesion Molecules Research (6 papers). Chi Dae Kim collaborates with scholars based in South Korea and United States. Chi Dae Kim's co-authors include Ki Whan Hong, So Youn Park, Won Suk Lee, Sun Sik Bae, Jeong Hyun Lee, Hwa Kyoung Shin, Byung Yong Rhim, Seung Jin Lee, Hye Young Kim and Sung Won Lee and has published in prestigious journals such as PLoS ONE, Stroke and Brain Research.

In The Last Decade

Chi Dae Kim

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Dae Kim South Korea 26 811 364 297 270 248 74 2.0k
So Youn Park South Korea 25 624 0.8× 311 0.9× 348 1.2× 236 0.9× 125 0.5× 56 1.6k
David Stegner Germany 33 1.0k 1.3× 608 1.7× 308 1.0× 467 1.7× 187 0.8× 98 3.3k
Zhi Yang China 34 1.4k 1.7× 296 0.8× 312 1.1× 229 0.8× 433 1.7× 66 2.6k
Giuseppe Straface Italy 24 667 0.8× 344 0.9× 163 0.5× 158 0.6× 175 0.7× 33 1.6k
Mohamed Al‐Shabrawey United States 38 1.2k 1.5× 434 1.2× 424 1.4× 165 0.6× 218 0.9× 82 3.6k
Ilaria Canobbio Italy 27 614 0.8× 242 0.7× 275 0.9× 342 1.3× 173 0.7× 57 1.9k
Jena J. Steinle United States 30 1.5k 1.8× 347 1.0× 264 0.9× 132 0.5× 337 1.4× 125 2.9k
Ping Xie China 28 1.4k 1.7× 507 1.4× 228 0.8× 174 0.6× 346 1.4× 128 3.4k
Li Zhu China 26 953 1.2× 310 0.9× 198 0.7× 296 1.1× 159 0.6× 91 2.1k
Gillian Douglas United Kingdom 24 677 0.8× 333 0.9× 523 1.8× 411 1.5× 242 1.0× 59 2.0k

Countries citing papers authored by Chi Dae Kim

Since Specialization
Citations

This map shows the geographic impact of Chi Dae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Dae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Dae Kim more than expected).

Fields of papers citing papers by Chi Dae Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Dae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Dae Kim. The network helps show where Chi Dae Kim may publish in the future.

Co-authorship network of co-authors of Chi Dae Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Dae Kim. A scholar is included among the top collaborators of Chi Dae Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Dae Kim. Chi Dae Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baek, Seung Eun, Eun Jeong Jang, Jong Min Choi, Young Whan Choi, & Chi Dae Kim. (2022). α-Iso-cubebene attenuates neointima formation by inhibiting HMGB1-induced monocyte to macrophage differentiation via suppressing ROS production. International Immunopharmacology. 111. 109121–109121. 6 indexed citations
2.
Lee, Seung Jin, et al.. (2019). SIRT1 inhibits monocyte adhesion to the vascular endothelium by suppressing Mac-1 expression on monocytes. Experimental & Molecular Medicine. 51(4). 1–12. 23 indexed citations
3.
Son, Yonghae, Bo-Young Kim, Young Chul Park, et al.. (2019). Cyclosporin A inhibits differentiation and activation of monocytic cells induced by 27-hydroxycholesterol. International Immunopharmacology. 69. 358–367. 12 indexed citations
4.
Park, So Youn, Hye Jin Heo, Hwa Kyoung Shin, et al.. (2019). Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model. Behavioural Brain Research. 365. 133–140. 6 indexed citations
5.
Kim, Jayoung, Dong‐Hoon Shin, Jee Yeon Kim, et al.. (2018). SURF4 has oncogenic potential in NIH3T3 cells. Biochemical and Biophysical Research Communications. 502(1). 43–47. 7 indexed citations
6.
Park, So Youn, Hye Rin Lee, Won Suk Lee, et al.. (2016). Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells. PLoS ONE. 11(8). e0160620–e0160620. 57 indexed citations
7.
Park, So Youn, Sung Won Lee, Won Suk Lee, et al.. (2013). RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: Suppression by cilostazol. Biochemical Pharmacology. 86(9). 1320–1327. 21 indexed citations
8.
Seo, Kyo Won, Seung Jin Lee, Yun Hak Kim, et al.. (2013). Mechanical Stretch Increases MMP-2 Production in Vascular Smooth Muscle Cells via Activation of PDGFR-β/Akt Signaling Pathway. PLoS ONE. 8(8). e70437–e70437. 50 indexed citations
9.
Park, Ji Young, Young Whan Choi, Jin Ung Bae, et al.. (2012). Gomisin J from Schisandra chinensis induces vascular relaxation via activation of endothelial nitric oxide synthase. Vascular Pharmacology. 57(2-4). 124–130. 27 indexed citations
10.
Lee, Seung Jin, et al.. (2012). Homocysteine enhances MMP-9 production in murine macrophages via ERK and Akt signaling pathways. Toxicology and Applied Pharmacology. 260(1). 89–94. 27 indexed citations
11.
Lee, Dong Hyung, Hye Rin Lee, Hwa Kyoung Shin, et al.. (2011). Cilostazol enhances integrin‐dependent homing of progenitor cells by activation of camp‐dependent protein kinase in synergy with Epac1. Journal of Neuroscience Research. 89(5). 650–660. 15 indexed citations
13.
Lee, Seung Jin, Sun Sik Bae, Won Suk Lee, et al.. (2007). High glucose enhances MMP‐2 production in adventitial fibroblasts via Akt1‐dependent NF‐κB pathway. FEBS Letters. 581(22). 4189–4194. 31 indexed citations
14.
Park, Won Sun, Sung Hyun Kang, Youn Kyoung Son, et al.. (2007). The mitochondrial Ca2+-activated K+ channel activator, NS 1619 inhibits L-type Ca2+ channels in rat ventricular myocytes. Biochemical and Biophysical Research Communications. 362(1). 31–36. 42 indexed citations
15.
Kim, Mi Jeong, Jeong Hyun Lee, So Youn Park, et al.. (2006). Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation. Pharmacological Research. 54(4). 261–267. 32 indexed citations
16.
Son, Seok Man, et al.. (2005). Tyrosine kinase-mediated activation of NAD(P)H oxidase enhances proliferative capacity of diabetic vascular smooth muscle cells. Life Sciences. 76(15). 1747–1757. 6 indexed citations
18.
Chun, Kook Jin, et al.. (2002). Mechanism of Impaired Endothelium-dependent Vasodilation in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats .. Korean Diabetes Journal. 26(1). 47–57. 1 indexed citations
19.
Choi, Jae Moon, Chi Dae Kim, & Ki Whan Hong. (2001). Involvement of NADH/NADPH oxidase-derived superoxide in experimental vasospasm induced by periarterial blood in rat femoral artery. Life Sciences. 69(15). 1753–1763. 6 indexed citations
20.
Hong, Ki Whan, et al.. (1998). PHARMACOLOGICAL PROFILES OF SKP-450 AND ITS FAMILY, A K+CHANNEL OPENER, IN COMPARISON WITH LEVCROMAKALIM. Pharmacological Research. 38(3). 191–197. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026